Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy
NCT00651222 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2008-04-02
Summary
The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.
Conditions
Interventions
- OTHER
-
No intervention was required
Death records were reviewed, therefore, there was no intervention
Sponsors & Collaborators
-
Prostate Cancer Foundation of Chicago
lead OTHER
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
NCT05611307 ·Status: TERMINATED
-
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
NCT00032006 ·Status: COMPLETED ·Phase: PHASE2
-
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
NCT00004124 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NCT05100472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
NCT00116142 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
NCT00002633 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
NCT00004054 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
NCT01226888 ·Status: TERMINATED
-
Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database
NCT06902441 ·Status: COMPLETED
-
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00528866 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624 ·Status: COMPLETED
-
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
NCT00500110 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
NCT00030654 ·Status: COMPLETED ·Phase: PHASE3
-
Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery
NCT01780220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00006359 ·Status: COMPLETED ·Phase: PHASE2
-
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT00002651 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
NCT06163924 ·Status: RECRUITING
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT00005044 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
NCT01250717 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
NCT00430183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00936390 ·Status: COMPLETED ·Phase: PHASE3
-
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
NCT05790213 ·Status: RECRUITING ·Phase: PHASE2
-
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
NCT01254513 ·Status: COMPLETED ·Phase: PHASE2
-
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
NCT04869371 ·Status: UNKNOWN ·Phase: PHASE2